Study Shows Vision, Anatomy Stable With Port System for AMD

Recalled in 2022, a port delivery system for ranibizumab to treat wet AMD demonstrated that vision and retinal anatomy remained stable in patients who had the device for 5 years.
Medscape Medical News

Full Story →